牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

近岸蛋白（688137）

4.8

综合诊断：4.8分打败了30%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
下跌有所减缓，仍应保持谨慎。
长期趋势：
已有39家主力机构披露2025-06-30报告期持股数据，持仓量总计1409.50万股，占流通A股43.14%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

5.3分

5.5分

1.9分

4.3分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：5.3技术面打败了53%的股票技术面评分前10的股票

近期的平均成本为41.77元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

技术面得分最高的股票

平均成本

近期的平均成本为41.77元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"41.77","date":1764478742,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，接近行业平均水平。

[{"date":"2025.11.28","stock":"1.81","trade":"0.19","ind":"0.34"},{"date":"2025.11.27","stock":"0.44","trade":"-0.26","ind":"0.29"},{"date":"2025.11.26","stock":"-0.89","trade":"0.65","ind":"-0.15"},{"date":"2025.11.25","stock":"1.68","trade":"1.51","ind":"0.87"},{"date":"2025.11.24","stock":"2.63","trade":"1.45","ind":"0.05"},{"date":"2025.11.21","stock":"-6.11","trade":"-3.82","ind":"-2.45"},{"date":"2025.11.20","stock":"-1.12","trade":"-0.92","ind":"-0.40"},{"date":"2025.11.19","stock":"-3.24","trade":"-1.90","ind":"0.18"},{"date":"2025.11.18","stock":"-0.25","trade":"-0.92","ind":"-0.81"},{"date":"2025.11.17","stock":"-1.15","trade":"-2.18","ind":"-0.46"},{"date":"2025.11.14","stock":"0.80","trade":"0.63","ind":"-0.97"},{"date":"2025.11.13","stock":"1.11","trade":"1.09","ind":"0.73"},{"date":"2025.11.12","stock":"0.57","trade":"0.87","ind":"-0.07"},{"date":"2025.11.11","stock":"1.10","trade":"0.43","ind":"-0.39"},{"date":"2025.11.10","stock":"0.18","trade":"1.72","ind":"0.53"},{"date":"2025.11.07","stock":"-0.09","trade":"-0.48","ind":"-0.25"},{"date":"2025.11.06","stock":"-0.16","trade":"-0.33","ind":"0.97"},{"date":"2025.11.05","stock":"-1.22","trade":"-0.81","ind":"0.23"},{"date":"2025.11.04","stock":"-1.32","trade":"-0.81","ind":"-0.41"},{"date":"2025.11.03","stock":"-0.36","trade":"0.04","ind":"0.55"},{"date":"2025.10.31","stock":"3.13","trade":"4.09","ind":"-0.81"}]

近岸蛋白,上证指数,生物制品指数

压力支撑

该股压力位为41.58元，支撑位为40.83元。

[{"text":"\u538b\u529b\u4f4d","value":"41.58","date":1764259200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"40.83","date":1764259200,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：5.5资金面打败了70%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码较分散，呈低度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体无进出。

更新时间：12月01日 13:44

机构今日流向(万元)	-219.15	机构5日流向(万元)	-734.35
机构10日流向(万元)	-11673.69	机构20日流向(万元)	-19253.53

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少20.72万股，其中基金净减仓2家，主力净增仓16家，暂未发现中长期投资价值。

截止2025-06-30，共39家主力机构（基金37家，一般法人2家），持仓量总计1409.5万股，占流通A股43.14%
其中，基金持仓与2024-12-31相比：
增仓：3家，增持 23.50万股
减仓：5家，减持 5.52万股
新出现在主力名单中：25家，持有138.92万股
从主力名单中消失：9家，原持有177.62万股

消息面诊股

诊断结果：5.5消息面打败了82%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	股东大会	临时股东大会	2025-11-26
一般消息	募资投向		2025-09-22
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	分红转增	不分配不转增	2025-04-29
利空	业绩预告	业绩预亏	2025-01-18

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	0条	1条

行业面诊股

诊断结果：1.9行业面打败了18%的股票生物制品行业最新资金流向

近10日来该行业走势总体向下，跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，跑输大盘。

[{"date":"2025.11.28","price":"0.34","value":"0.19"},{"date":"2025.11.27","price":"0.29","value":"-0.26"},{"date":"2025.11.26","price":"-0.15","value":"0.65"},{"date":"2025.11.25","price":"0.87","value":"1.51"},{"date":"2025.11.24","price":"0.05","value":"1.45"},{"date":"2025.11.21","price":"-2.45","value":"-3.82"},{"date":"2025.11.20","price":"-0.40","value":"-0.92"},{"date":"2025.11.19","price":"0.18","value":"-1.90"},{"date":"2025.11.18","price":"-0.81","value":"-0.92"},{"date":"2025.11.17","price":"-0.46","value":"-2.18"},{"date":"2025.11.14","price":"-0.97","value":"0.63"},{"date":"2025.11.13","price":"0.73","value":"1.09"},{"date":"2025.11.12","price":"-0.07","value":"0.87"},{"date":"2025.11.11","price":"-0.39","value":"0.43"},{"date":"2025.11.10","price":"0.53","value":"1.72"},{"date":"2025.11.07","price":"-0.25","value":"-0.48"},{"date":"2025.11.06","price":"0.97","value":"-0.33"},{"date":"2025.11.05","price":"0.23","value":"-0.81"},{"date":"2025.11.04","price":"-0.41","value":"-0.81"},{"date":"2025.11.03","price":"0.55","value":"0.04"},{"date":"2025.10.31","price":"-0.81","value":"4.09"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	金迪克	58.38%	31.29%	4.8分
2	博晖创新	21.35%	6.23%	4.3分
3	万泽股份	18.81%	1.33%	5.4分
4	特宝生物	6.57%	-0.70%	6.3分
5	诺诚健华	6.11%	11.43%	5.8分
6	康华生物	5.92%	5.86%	5.3分
7	华兰疫苗	5.10%	8.56%	5.1分
8	*ST四环	3.66%	4.08%	5.8分
9	欧林生物	2.83%	19.94%	6.9分
10	东宝生物	2.33%	4.40%	5.5分
11	ST未名	0.90%	0.90%	4.7分
12	优宁维	0.78%	5.14%	5.5分
13	荣昌生物	0.59%	15.39%	6.6分
14	智飞生物	-0.15%	1.83%	4.3分
15	沃森生物	-0.57%	0.50%	4.7分
16	百克生物	-1.46%	2.37%	5.0分
17	上海莱士	-1.63%	0.30%	4.9分
18	成大生物	-2.41%	1.06%	4.9分
19	通化东宝	-2.66%	3.05%	5.6分
20	诺唯赞	-3.06%	2.84%	5.1分
21	卫光生物	-3.40%	1.61%	5.1分
22	华兰生物	-3.41%	0.52%	5.0分
23	赛伦生物	-3.98%	4.70%	5.4分
24	派林生物	-4.64%	-3.10%	4.6分
25	赛升药业	-5.46%	3.61%	4.1分
26	近岸蛋白	-5.78%	5.76%	4.8分
27	博雅生物	-5.90%	-0.63%	4.4分
28	天坛生物	-6.19%	-1.82%	4.9分
29	甘李药业	-6.34%	5.03%	5.7分
30	康泰生物	-6.45%	-0.06%	4.2分
31	康弘药业	-6.91%	4.58%	5.6分
32	我武生物	-7.27%	4.97%	5.2分
33	辽宁成大	-7.76%	-0.59%	5.1分
34	君实生物	-8.10%	3.78%	5.5分
35	智翔金泰	-8.67%	3.36%	4.4分
36	百奥泰	-8.92%	2.36%	5.3分
37	西藏药业	-8.94%	0.93%	4.8分
38	-	-9.02%	-3.33%	分
39	迈威生物	-9.22%	7.48%	5.5分
40	安科生物	-9.44%	0.10%	4.4分
41	百普赛斯	-9.59%	2.11%	4.8分
42	义翘神州	-9.62%	1.48%	5.0分
43	三生国健	-9.91%	3.69%	5.6分
44	神州细胞	-10.04%	4.64%	5.6分
45	艾迪药业	-10.11%	2.99%	5.3分
46	凯因科技	-10.51%	4.02%	5.2分
47	昊帆生物	-10.60%	1.97%	4.3分
48	-	-10.81%	0.08%	分
49	康辰药业	-11.52%	4.49%	5.7分
50	长春高新	-11.58%	0.35%	4.8分
51	*ST双成	-12.50%	-1.89%	4.4分
52	康希诺	-13.53%	2.47%	4.7分
53	-	-14.14%	-1.05%	分
54	科兴制药	-18.33%	4.17%	5.6分
55	禾元生物	-36.06%	2.60%	4.9分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.3基本面打败了3%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（82.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 39/72 ， 35/72。

[{"date":"2025-09-30","value":"-1.38","vol":"-9.78"},{"date":"2025-06-30","value":"-1.16","vol":"-0.61"},{"date":"2025-03-31","value":"-0.56","vol":"0.46"},{"date":"2024-12-31","value":"-2.54","vol":"-0.68"},{"date":"2024-09-30","value":"-0.84","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-1.38	-1.16	-0.56	-2.54	-0.84
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"64.84","vol":"67.61"},{"date":"2025-06-30","value":"64.47","vol":"68.28"},{"date":"2025-03-31","value":"62.26","vol":"68.43"},{"date":"2024-12-31","value":"62.38","vol":"69.85"},{"date":"2024-09-30","value":"64.54","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	64.84	64.47	62.26	62.38	64.54
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，两项指标的行业排名分别为 17/72 ， 42/72。

[{"date":"2025-09-30","value":"21.48","vol":"45.25"},{"date":"2025-06-30","value":"20.85","vol":"6902.04"},{"date":"2025-03-31","value":"28.20","vol":"6125.27"},{"date":"2024-12-31","value":"-16.73","vol":"47.35"},{"date":"2024-09-30","value":"-16.83","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	21.48	20.85	28.20	-16.73	-16.83
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-58.06","vol":"44.80"},{"date":"2025-06-30","value":"-172.00","vol":"5.44"},{"date":"2025-03-31","value":"-348.91","vol":"-8.46"},{"date":"2024-12-31","value":"-523.68","vol":"-9.81"},{"date":"2024-09-30","value":"-215.00","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-58.06	-172.00	-348.91	-523.68	-215.00
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 50/72 ， 38/72。

[{"date":"2025-09-30","value":"0.05","vol":"0.22"},{"date":"2025-06-30","value":"0.03","vol":"0.14"},{"date":"2025-03-31","value":"0.02","vol":"0.06"},{"date":"2024-12-31","value":"0.06","vol":"0.29"},{"date":"2024-09-30","value":"0.04","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.05	0.03	0.02	0.06	0.04
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.54","vol":"0.92"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.17","vol":"0.26"},{"date":"2024-12-31","value":"0.60","vol":"1.17"},{"date":"2024-09-30","value":"0.40","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.54	0.36	0.17	0.60	0.40
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-8.59","vol":"1.84"},{"date":"2025-06-30","value":"-2.09","vol":"-1377.61"},{"date":"2025-03-31","value":"-39.69","vol":"-46.99"},{"date":"2024-12-31","value":"-18.41","vol":"-11.33"},{"date":"2024-09-30","value":"-10.65","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-8.59	-2.09	-39.69	-18.41	-10.65
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.53","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.26","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.53	-	1.26	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 50/72 ， 47/72。

[{"date":"2025-09-30","value":"25.67","vol":"6.00"},{"date":"2025-06-30","value":"25.93","vol":"6.64"},{"date":"2025-03-31","value":"25.98","vol":"7.75"},{"date":"2024-12-31","value":"29.13","vol":"6.72"},{"date":"2024-09-30","value":"36.07","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	25.67	25.93	25.98	29.13	36.07
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"11.73","vol":"4.84"},{"date":"2025-06-30","value":"11.47","vol":"5.30"},{"date":"2025-03-31","value":"10.22","vol":"6.35"},{"date":"2024-12-31","value":"10.63","vol":"5.40"},{"date":"2024-09-30","value":"13.49","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	11.73	11.47	10.22	10.63	13.49
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 47/72 ， 46/72。

[{"date":"2025-09-30","value":"5.23","vol":"28.18"},{"date":"2025-06-30","value":"5.30","vol":"26.73"},{"date":"2025-03-31","value":"5.49","vol":"26.03"},{"date":"2024-12-31","value":"5.25","vol":"25.81"},{"date":"2024-09-30","value":"4.85","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	5.23	5.30	5.49	5.25	4.85
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.06","vol":"0.58"},{"date":"2025-06-30","value":"0.06","vol":"1.11"},{"date":"2025-03-31","value":"0.06","vol":"0.78"},{"date":"2024-12-31","value":"0.06","vol":"0.87"},{"date":"2024-09-30","value":"0.05","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.06	0.06	0.06	0.06	0.05
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"1.49","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.54","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[近岸蛋白]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]